Total Payments
$214,695
2024 Payments
$7,282
Companies
53
Transactions
590
Medicare Patients
3,076
Medicare Billing
$439,566
Payment Breakdown by Category
Other$147,252 (68.6%)
Consulting$33,311 (15.5%)
Travel$18,831 (8.8%)
Food & Beverage$15,113 (7.0%)
Education$187.54 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $131,452 | 65 | 61.2% |
| Consulting Fee | $33,311 | 15 | 15.5% |
| Travel and Lodging | $18,831 | 51 | 8.8% |
| Honoraria | $15,800 | 7 | 7.4% |
| Food and Beverage | $15,113 | 447 | 7.0% |
| Education | $187.54 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $84,923 | 115 | $0 (2023) |
| Genentech USA, Inc. | $34,498 | 72 | $0 (2023) |
| EMD Serono, Inc. | $23,177 | 52 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $20,283 | 37 | $0 (2023) |
| Horizon Therapeutics plc | $18,106 | 27 | $0 (2023) |
| ABBVIE INC. | $16,225 | 50 | $0 (2024) |
| Biogen, Inc. | $13,232 | 43 | $0 (2023) |
| UCB, Inc. | $340.30 | 14 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $297.07 | 24 | $0 (2024) |
| Mallinckrodt LLC | $241.83 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,282 | 20 | ABBVIE INC. ($6,487) |
| 2023 | $51,886 | 140 | EMD Serono, Inc. ($15,445) |
| 2022 | $20,007 | 216 | Genentech USA, Inc. ($6,527) |
| 2021 | $24,233 | 27 | GENZYME CORPORATION ($10,107) |
| 2020 | $14,470 | 18 | Biogen, Inc. ($4,320) |
| 2019 | $32,060 | 59 | Genentech USA, Inc. ($23,271) |
| 2018 | $18,473 | 43 | GENZYME CORPORATION ($16,939) |
| 2017 | $46,283 | 67 | GENZYME CORPORATION ($45,910) |
All Payment Transactions
590 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Immunology | ||||||
| 09/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,675.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $37.49 | General |
| 08/15/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $117.18 | General |
| Category: Neurology | ||||||
| 08/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $103.89 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Neuroscience | ||||||
| 06/14/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $7.86 | General |
| 06/04/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $20.42 | General |
| 05/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Immunology | ||||||
| 05/09/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $83.42 | General |
| Category: NEUROSCIENCE | ||||||
| 05/04/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $26.73 | General |
| 04/29/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.99 | General |
| Category: Neuroscience | ||||||
| 04/24/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $37.56 | General |
| 04/08/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.86 | General |
| Category: Neuroscience | ||||||
| 02/24/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $87.66 | General |
| Category: Neurology | ||||||
| 02/24/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $37.49 | General |
| 02/24/2024 | Genentech, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Immunology | ||||||
| 02/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.85 | General |
| Category: PSYCHIATRY | ||||||
| 02/13/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $63.47 | General |
| 11/28/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $102.48 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 280 | 331 | $100,554 | $34,853 |
| 2022 | 5 | 193 | 205 | $69,180 | $25,979 |
| 2021 | 17 | 1,246 | 8,130 | $566,093 | $185,921 |
| 2020 | 20 | 1,357 | 17,938 | $657,489 | $192,813 |
Total Patients
3,076
Total Services
26,604
Medicare Billing
$439,566
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 113 | $26,216 | $10,043 | 38.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 59 | 59 | $26,491 | $8,265 | 31.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 45 | 58 | $18,154 | $7,153 | 39.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 64 | 64 | $22,848 | $6,935 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 37 | $6,845 | $2,457 | 35.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 63 | 63 | $28,287 | $10,313 | 36.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $17,850 | $5,935 | 33.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 32 | $10,016 | $4,387 | 43.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 41 | $9,512 | $4,056 | 42.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 19 | $3,515 | $1,289 | 36.7% |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | Office | 2021 | 137 | 137 | $131,109 | $57,335 | 43.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 11 | 6,700 | $134,000 | $32,488 | 24.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 229 | 292 | $67,160 | $23,392 | 34.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 107 | 126 | $41,958 | $16,517 | 39.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 115 | 115 | $44,361 | $13,796 | 31.1% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 119 | 137 | $37,401 | $10,877 | 29.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 54 | 54 | $26,296 | $9,076 | 34.5% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2021 | 60 | 60 | $26,160 | $6,550 | 25.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 94 | 103 | $15,656 | $5,980 | 38.2% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 24 | 24 | $13,776 | $3,424 | 24.9% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 21 | 21 | $14,574 | $3,191 | 21.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 14 | 14 | $3,819 | $1,034 | 27.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 68 | 93 | $3,348 | $982.08 | 29.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 68 | 96 | $3,264 | $745.92 | 22.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 99 | 131 | $2,620 | $393.00 | 15.0% |
About Dr. Susan Evans, MD
Dr. Susan Evans, MD is a Neurology healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1487658415.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susan Evans, MD has received a total of $214,695 in payments from pharmaceutical and medical device companies, with $7,282 received in 2024. These payments were reported across 590 transactions from 53 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($131,452).
As a Medicare-enrolled provider, Evans has provided services to 3,076 Medicare beneficiaries, totaling 26,604 services with total Medicare billing of $439,566. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Greenville, NC
- Active Since 06/08/2005
- Last Updated 03/09/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1487658415
Products in Payments
- AUBAGIO (Drug) $62,805
- OCREVUS (Biological) $34,346
- LEMTRADA (Drug) $22,309
- UPLIZNA (Drug) $18,106
- QULIPTA (Drug) $15,810
- MAVENCLAD (Drug) $15,222
- Mavenclad (Drug) $7,347
- Soliris (Drug) $4,429
- SOLIRIS (Biological) $4,202
- ULTOMIRIS (Biological) $2,710
- TYSABRI (Biological) $1,920
- VUMERITY (Drug) $1,309
- BOTOX (Biological) $289.00
- KESIMPTA (Drug) $278.50
- ACTHAR (Biological) $241.83
- AUSTEDO (Drug) $200.45
- ZEPOSIA (Drug) $185.76
- BRIUMVI (Drug) $184.51
- UBRELVY (Drug) $181.46
- RYTARY (Drug) $177.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Greenville
Mary Hughes, Md, MD
Neurology — Payments: $544,207
Neurology $544,207
Dr. James Cooper, M.d, M.D
Neurology — Payments: $300,188
Neurology $300,188
Fredy Revilla, M.d, M.D
Neurology — Payments: $251,715
Neurology $251,715
Dr. John Porter, Md, MD
Neurology — Payments: $143,009
Neurology $143,009
Kathleen Woschkolup, Md, MD
Neurology — Payments: $124,535
Neurology $124,535
Dr. Amber Stutz, Md, MD
Neurology — Payments: $50,564
Neurology $50,564